Reduction of femoral artery bleeding post catheterization using a collagen enhanced fibrin sealant

Falstrom, Jeanne K.; Goodman, Norman C.; Ates, Gursel; Abbott, Robert D.; Powers, Eric R.; Spotnitz, William D.

doi:10.1002/(sici)1097-0304(199705)41:1<79::aid-ccd18>3.0.co;2-l

Cited by 14 publications

(2 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These efforts included work in a variety of surgical disciplines including breast [9, 13, 14, 16, 17, 32, 36], cardiovascular [11, 26, 27, 30, 33], gastrointestinal [10], head and neck [22, 35], hepatic [12, 20], neuro- [29], orthopedic [21, 37, 40, 41], pediatric [12], noncardiac thoracic [25, 30, 31, 33, 34], and vascular surgery [15, 18, 19, 23, 24, 38, 39]. This body of work emphasized the evolving versatility of fibrin sealant because it is capable of causing blood to clot, creating a sealing barrier, and gluing tissues together.…”

Section: Introductionmentioning

confidence: 99%

Fibrin Sealant: The Only Approved Hemostat, Sealant, and Adhesive—a Laboratory and Clinical Perspective

2014

Self Cite

View full text Add to dashboard Cite

Background. Fibrin sealant became the first modern era material approved as a hemostat in the United States in 1998. It is the only agent presently approved as a hemostat, sealant, and adhesive by the Food and Drug Administration (FDA). The product is now supplied as patches in addition to the original liquid formulations. Both laboratory and clinical uses of fibrin sealant continue to grow. The new literature on this material also continues to proliferate rapidly (approximately 200 papers/year). Methods. An overview of current fibrin sealant products and their approved uses and a comprehensive PubMed based review of the recent literature (February 2012, through March 2013) on the laboratory and clinical use of fibrin sealant are provided. Product information is organized into sections based on a classification system for commercially available materials. Publications are presented in sections based on both laboratory research and clinical topics are listed in order of decreasing frequency. Results. Fibrin sealant remains useful hemostat, sealant, and adhesive. New formulations and applications continue to be developed. Conclusions. This agent remains clinically important with the recent introduction of new commercially available products. Fibrin sealant has multiple new uses that should result in further improvements in patient care.

show abstract

Section: Introductionmentioning

confidence: 99%

Fibrin Sealant: The Only Approved Hemostat, Sealant, and Adhesive—a Laboratory and Clinical Perspective

2014

Self Cite

View full text Add to dashboard Cite

show abstract

“…While traditional open surgery can benefit from surgical sutures and mechanical tissue fusion, both carry the risk of intolerance and toxicity [24,25]. Additionally, the use of haemostatic agents, such as fibrin sealants or collagen-based products, can achieve haemostasis and provide additional wound support, especially when it comes to the arteriotomy [26,27].…”

Section: Closure Techniques For Open Femoral Proceduresmentioning

confidence: 99%

Endovascular procedures and nursing care: managing vascular access wounds

Dziekiewicz,

Bystron,

Kobiałka

et al. 2023

pcia

View full text Add to dashboard Cite

The common femoral artery (CFA) is frequently utilized access site for endovascular procedures, but this approach can lead to several complications, including haematomas, pseudoaneurysms, bleeding at the access site, and surgical site infections (SSI). Although appropriate management of vascular access wounds can minimize the risk of complications, SSI is still a significant concern for patients undergoing endovascular procedures. Therefore, nursing personnel must possess comprehensive knowledge of the techniques used to access CFA, potential complications, and the nursing care required to manage them effectively. Nurses play a critical role in preventing complications associated with endovascular procedures, as they can identify patients with a high risk of complications. With appropriate education, nurses can inform patients about the measures that can be taken to reduce the risk of adverse events. Regular assessment and monitoring of the wound are essential for the early detection of complications and the implementation of measures to minimize their negative effects.

show abstract